Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 4, 2007

View Archived Issues

Multiple studies of SCH-527123 in healthy subjects reported

Phase III, other data on bazedoxifene presented

Snapshots of recent in vitro and pharmacokinetic studies of ceftaroline

NeuroSearch seeks approval in Europe to commence phase III trials with ACR-16

(R)-(+) isomer of zileuton enters clinical trials

Not approvable letter assigned for expanded indication for Frova

Trophos begins patient enrollment for TRO-19622 SMA trial

DiaMedica reports promising phase II results with DM-71 for type 2 diabetes

Primary endpoint not reached in phase IIb trial of ANX-510

One-year treatment with tesamorelin shows promise in phase III trial

FDA approves SymlinPen device and issues not approvable letter for expanded Symlin indication

Kyorin launches bronchial asthma treatment for young children

Preclinical antidiabetic activity of Chinese herbal medicinal compound DC-250188

Preclinical profile of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic

Topical nerve growth factor relieves dry eye symptoms in vivo

Recent AstraZeneca patents describe new antiasthmatic agents

Novel coagulation factor VIIa inhibitors emerge from Bristol-Myers Squibb R&D

GlaxoSmithKline discovers novel antianemic agents

Phase II studies show activity of SNS-595 in lung cancer

Axcan licenses rights to Cx-401 for perianal fistulas

FASgen achieves significant milestone in cancer drug program

Isis grants rights to two diabetes drugs to Ortho-McNeil

Newron initiates phase II studies for ralfinamide in post-surgical pain

OSI and Aveo collaborate on oncology drug discovery program

Daiichi Sankyo seeks approval of combination hypertension candidate in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...